SSI INVESTMENT MANAGEMENT LLC - UNITED THERAPEUTICS CORP DEL ownership

Quarter-by-quarter ownership
SSI INVESTMENT MANAGEMENT LLC ownership history of UNITED THERAPEUTICS CORP DEL
ValueSharesWeighting
Q2 2015$47,000
-97.8%
13,000
-97.8%
0.01%
-97.5%
Q1 2015$2,162,000
+33.0%
600,0000.0%0.20%
+23.6%
Q4 2014$1,625,000
+0.8%
600,000
+0.2%
0.16%
+5.1%
Q3 2014$1,612,000
+42.2%
599,000
-0.2%
0.16%
+42.7%
Q2 2014$1,134,000
-31.4%
600,000
-27.7%
0.11%
-34.9%
Q1 2014$1,652,000
+19.5%
830,000
+42.4%
0.17%
+37.4%
Q4 2013$1,383,000
+37.6%
583,000
-1.7%
0.12%
+35.2%
Q3 2013$1,005,000
+12.9%
593,000
-3.6%
0.09%
+4.6%
Q2 2013$890,000615,0000.09%
Other shareholders
UNITED THERAPEUTICS CORP DEL shareholders Q3 2023
NameSharesValueWeighting ↓
Sage Capital Management, LLC 2,500,000$4,245,0004.05%
WHITEBOX ADVISORS LLC 34,365,000$58,350,0003.08%
BASSO CAPITAL MANAGEMENT, L.P. 10,000,000$16,963,0002.96%
CAMDEN ASSET MANAGEMENT L P /CA 21,257,000$36,084,0002.17%
GRACE BROTHERS MANAGEMENT LLC 1,500,000$2,549,0002.17%
Ferox Capital Management LP 3,000,000$5,101,0001.96%
Castle Creek Arbitrage, LLC 20,700,000$35,185,0001.57%
Polar Asset Management Partners Inc. 20,000,000$34,012,0001.44%
SYMPHONY ASSET MANAGEMENT LLC 7,712,000$13,091,0001.33%
Verition Fund Management LLC 2,500,000$4,256,0000.64%
View complete list of UNITED THERAPEUTICS CORP DEL shareholders